BRCA1 and ovarian cancer: The aim of this study was to screen seven known BrCa susceptibility genes for additional mutations in 82 well-characterized, Finnish, high-risk hereditary breast and/or ovarian cancer (HBOC) individuals tested to be BRCA1/2-founder mutation negative.